CorVista System

Cardiac Analysis Platform

The only non-invasive way for physicians to assess for elevated left ventricular end diastolic pressure (LVEDP ≥ 20 mmHg) within minutes at point-of-care.

FDA cleared

Under investigation to asses likelihood of diastolic dysfunction

Under investigation to asses likelihood of elevated pulmonary pressure

How It Works

Point-of-Care Testing

Cardiac voltage gradient and hemodynamic signals are collected synchronously while patient is at rest

Watch Video

Machine-Learned Analysis in the Cloud

Millions of data points on cardiac and respiratory systems are analyzed by an FDA-cleared, machine-learned algorithm to predict likelihood of elevated LVEDP

Watch Video

Download Security Fact Sheet

Rapid Results at Physician's Fingertips

CorVista® HF Analysis is available to physicians in a secure, web portal with minutes of the test being completed

Watch Video

Hear what physicians have to say about the CorVista System